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Abstract 
 
A 23-year-old lady presented with both eye progressive painless blurring of vision for two weeks in 2011. Prior to 
that she had malar rash, hair loss, photosensitivity and bilateral leg swelling. Ocular examination showed that visual 
acuity on the right was 6/60 and on the left was 6/24. Both optic disc were swollen with extensive peripapillary 
cotton wool spot (CWS), flame shape haemorrhages, dilated and tortuous vessels with macular oedema. Systemic 
examination revealed blood pressure of 176/111 mmHg, malar rash and alopecia. Diagnosis of grade 4 hypertensive 
retinopathy secondary to SLE was made. The diagnosis was confirmed by positive ANA/ dsDNA, low C3/ C4 and 
renal biopsy showed lupus nephritis. She was treated with oral prednisolone, hydroxychloroquine and cyclosporin A. 
Throughout the monitoring for hydroxychloroquine toxicity, vision over both eyes were 6/9, but serial visual fields 
showed non-progressive left superior and inferior scotoma while right eye showed inferior scotoma. The intraocular 
pressure was normal with pink optic disc and cup disc ratio of 0.3. Optical coherence tomography (OCT) showed 
temporal and nasal retinal nerve fiber layer thinning bilaterally. However, macula OCT, fundus fluorescein 
angiography and autofluorescence were normal. The visual field defect was concluded secondary to CWS indicating 
microinfarction of the retinal nerve fiber secondary to previous hypertensive retinopathy. Non-progressive visual 
field defects may occur after the appearance of CWS in hypertensive retinopathy and it should not be overlooked 
when diagnosing glaucoma or hydroxychloroquine toxicity. 
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Introduction 
 
Systemic lupus erythematosus (SLE) is an 
autoimmune disease with a wide range of clinical 
manifestation which can affect any organ in the body 
(1). Secondary malignant hypertension resulting from 
renal parenchymal lesion is part of the disease entity. 
Malignant hypertension may affect the eye in various 
ways but grade III or IV hypertensive retinopathy with 
ischemic retinal injury can be visually disabling. 
Cotton wool spots seen in grade III and IV 
hypertensive retinopathy indicates microinfarction of 
the retinal nerve fibers and neuronal loss which can 
results in subsequent related scotoma (2). Hereby, we 
describe a case of lupus nephritis with grade 4 
hypertensive retinopathy presenting with multiple 
peripapillary cotton wool spots which eventually 
causes permanent visual field defect.    
 
Case Report 
 
A 23-year-old lady presented with both eye 
progressive painless blurring of vision for two weeks 
in 2011. Prior to that she had malar rash, hair loss, 
photosensitivity and bilateral leg swelling. The past 
medical and family history were insignificant.  
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Figure 1: a) Optic disc photo taken in year 2011 showed hypertensive retinopathy as evidenced by hyperemic swollen disc, 
extensive peripapillary cotton wool spots and flame shape haemorrhages; b) Optic disc photo taken in 2016 showed pink optic 
disc with cup/disc ratio 0.3, no neuroretinal rim thinning, scant gliosis more on right eye; c) OCT RNFL showed thinning of 
bilateral temporal quadrant, right nasal quadrant and left infero-nasal quadrant. 
 
Ocular examination showed that visual acuity on the 
right was 6/60 and left 6/24. There was no relative 
afferent pupillary defect. Anterior segment and 
intraocular pressure were normal. Fundoscopic 
examination showed bilateral optic disc swelling with 
blurred disc margin, extensive peripapillary cotton 
wool spot (CWS), flame shape haemorrhages, dilated 
and tortous vessels and macular oedema (Fig. 1a). 
Systemic examination showed blood pressure of 
176/111 mmHg, malar rash, discoid rash over the 
scalp, alopecia and vasculitic lesions over her palms.  
 
The blood investigation showed positive 
ANA/dsDNA, low C3/C4, macrocytic anemia with 
positive direct coomb’s test and raised reticulocyte 
count. Urinalysis showed proteinuria with microscopic 
haematuria and renal biopsy revealed diffuse active 
proliferative and membranous lupus nephritis (WHO 
class IV & V) with 56% cellular crescent. Otherwise, 
the renal function test was normal and computed 
tomography (CT) of the brain did not show features of 
posterior reversible encephalopathy syndrome (PRES).  
A diagnosis of SLE with grade IV hypertensive 
retinopathy secondary to lupus nephritis, autoimmune 
hemolytic anemia and discoid lupus was made. She 
was treated with intravenous (IV) methylprednisolone, 
double-filtration plamapheresis with IV 
immunoglobulin and IV cyclophosphamide. 
Subsequently, the prednisolone was tapered off and 
she was maintained on HCQ 200mg daily. 
 
She was seen in Ophthalmology clinic for screening of 
hydroxychloroquine toxicity. Throughout the follow 
up, her visual acuity remained stable at 6/9 in both eyes  
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Figure 2: Serial visual field showed persistent left superior and inferior arcuate scotoma and right inferior arcuate scotoma with 
lesser density over time. (RE, right eye; LE, left eye) 
 
with normal intraocular pressure. The optic disc was 
pink, cup to disc ratio was 0.3 with no neuroretinal rim 
thinning (Fig. 1b). However, serial visual fields 
showed left superior and inferior arcuate scotoma and 
right inferior field defect which was getting less dense. 
The latest visual field showed left superior arcuate and 
inferior paracentral scotoma while the right had some 
residual inferior paracentral scotoma (Fig. 2). The 
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color vision test was normal. A possibility of HCQ 
toxicity was ruled out as the fundus fluorescein 
angiography (FFA), fundus autofluorescence (FAF) 
and optical coherence tomography (OCT) macular 
were normal. OCT of retinal nerve fiber layer (RNFL) 
however showed thinning in both eyes (Fig. 1c). The 
visual field defect was concluded secondary to CWS 
indicating microinfarction of the retinal nerve fiber 
secondary to previous hypertensive retinopathy due to 
lupus nephritis. 
 
Discussion 
 
SLE is a multisystem, autoimmune, connective-tissue 
disorder with various clinical presentation and follows 
a relapsing and remitting course (1). The management 
often depends on disease severity and clinical 
manifestation. Medications include antimalarials (e.g. 
HCQ), nonsteroidal anti-inflammatory drugs 
(NSAIDS), steroids, non-biologic and biologic 
disease-modifying antirheumatic drugs (DMARDs). 
HCQ is important for long-term treatment of SLE as 
LUMINA (Lupus in Minorities: Nature versus 
Nurture) study and other trials have shown a decrease 
in flares and prolonged life in patients treated with 
HCQ (3). 
 
However, HCQ has been known to cause retinal 
toxicity for many years and ophthalmology screening 
is necessary. The mechanism of retinal toxicity though 
is not well understood but the primary damage is to the 
photoreceptors followed by disruption of the RPE (4). 
HCQ retinopathy is irreversible. Thus, early detection 
of retinopathy is important before RPE damage as 
there is only limited progression after stopping the 
medication and the fovea is not threatened (5). 
Recommended screening tests are automated visual 
fields and spectral-domain OCT macular (6). Our 
patient was noted to have non-progressive arcuate 
scotoma in both eyes by serial visual fields in contrast 
to the progressive nature of visual field defect seen in 
HCQ retinopathy. Furthermore, the macular OCT did 
not show loss of outer nuclear layer or RPE disruption 
and the FAF did not show increased fluorescence at 
the parafoveal or over the macular region. Neither did 
FFA showed any hyperfluorescence lesion which 
represents RPE defects. A multifocal 
electroretinogram (mfERG) may confirm the diagnosis 
of HCQ toxicity. The thinning seen on the 
peripapillary RNFL OCT was not consistent with the 
clinical examination of the optic disc. Therefore, the 
diagnosis of glaucoma was excluded.  
 
CWS is the clinical manifestation of focal infarcts of 
nerve fiber layer. It is localized accumulations of 
axoplasmic debris in the retinal ganglion cells axon 
after arteriolar occlusion at the borders of ischemic 
areas (7). The underlying cause is multiple and include 
accelerated hypertension. Uncontrolled systemic 
hypertension leads to various levels of retinal non-
perfusion and neuronal loss with subsequent related 
scotoma (2). Koh et al. reported four cases of 
nonprogressive localized RNFL and visual field 
defects after emergence of retinal CWS after followed 
up for 3 to 19 years. He concluded that it is crucial to 
consider the visual field results, disc configuration, 
RNFL defects and fundus findings to decide on the 
proper diagnosis in patients suspected to have 
glaucoma (8). On the other hand, Alencar et al. also 
reported a case of localized RNFL loss with 
corresponding arcuate defect developing after a retinal 
CWS in a patient with diabetes and hypertension (9). 
Chaum et al. also reported a similar case whereby a 
large idiopathic peripapillary CWS causing nerve fiber 
bundle visual field defect and an afferent pupillary 
defect that remained even after the CWS had 
disappeared (10). Our patient had arcuate scotoma 
which became less dense throughout follow up. This 
finding was not reported in the previous the case 
reports. 
 
Conclusion 
 
In this case, non-progressive visual field defect 
secondary to previous hypertensive retinopathy was 
noted during regular ophthalmology screening for 
hydroxychloroquine retinopathy. This non-progressive 
visual field defect may occur after the appearance of 
CWS in hypertensive retinopathy and it should not be 
overlooked when diagnosing glaucoma or 
hydroxychloroquine toxicity. 
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